Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 04/02/15

TPB Publications

2003 Publications

  1. Jia, L. Wong, H. Wang, Y. Garza, M. Weitman, S. 2003. Carbendazim: Disposition, cellular permeability, metabolite identification and pharmacokinetic comparison with its nanoparticle. J. Pharm. Sci. 92:161-172.
  2. Jia, L. Schweizer, J. Cerna, C. Wong, H. Revilla, M. 2003. Effect of Nitric Oxide on Cytotoxicity of Taxol: enhanced Taxol transcellular permeability. Biochemical Pharmacol. 66: 2193-2199,.
  3. Fry, T.J., Moniuszko, M., Creekmore, S., Donohue, S.J., Douek, D.C., Giardina, S., Hecht, T.T., Hill, B.J., Komschlies, K., Tomaszewski, J., Franchini, G., Mackall, C.L., 2003. IL-7 Therapy Dramatically Alters Peripheral T-cell Homeostasis in Normal and SIV-Infected Nonhuman Primates. Blood 101:2294-2299.
  4. Musser, S. M., M.J. Egorin,, E.G. Zuhowski, D.R. Hamburger, R.A. Parise, J.M. Covey, et al., 2003. Biliary Excretion of 17-(Allylamino)-17-demethoxygeldanamycin (NSC 330507) and Metabolites by Fischer 344 Rats. Cancer Chemother. Pharmacol., 52, 139-146.
  5. Mirsalis, J.C., Schindler-Horvat, J., Hill, J.R., Green, C.E., Mitoma, C., Tomaszewski, J.E., , Tyson, C.A., and Donohue, S.J., 2003: Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcome. Cancer Chemother. Pharmacol. 51:193-201.
  6. Chamberlain, P., Fowler, B., Sexton, M., Peggins, J., & Bredow, J. (2003). Preliminary studies of offspring exposure to phenylbutazone and ivermectin during the perinatal period in a Holstein cow-calf model. Toxicology and applied pharmacology , 187 (3), 198-208.

About the Branch Chief

For information regarding the TPB, please contact Dr. Jerry M. Collins, Associate Director, collinsje@mail.nih.gov